(RTTNews) - Catalent Inc. (CTLT) and Novo Holdings A/S announced that the companies have fulfilled all regulatory closing conditions for their pending transaction. The companies now expect to close ...
Catalent's acquisition by Novo Holdings faces regulatory updates. UK sees a preference for Mounjaro over Wegovy. This image ...
The drug candidate is developed based on SNAC technology. Novo Nordisk, a subsidiary of Novo Holdings AS, is a healthcare company with focus on discovering, developing, and manufacturing biological ...
Danish pharma company Novo Nordisk, makers of weight-loss drugs Ozempic and Wegovy, plans to expand production based on a takeover of US health products ma ...
A Russian oil tanker carrying thousands of tons of oil products split apart during a heavy storm on Sunday (December 15), ...
South Korea's acting president, Han Duck-soo, spoke with U.S. President Joe Biden on Sunday (December 15) to calm worries ...
Novo Holdings in February agreed to buy Catalent to boost output of the popular weight-loss drug Wegovy. According to the terms of the deal, Novo Holdings would sell three of Catalent's factories, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback